{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"125-092-023-472-056","frontPageModel":{"patentViewModel":{"ref":{"entityRefType":"PATENT","entityRefId":"125-092-023-472-056"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":11849,"type":"PATENT","title":"University of Liege Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":6891,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8461,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately:univ* AND Liege. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1416
Search Applicants and Owners separately:univ* AND Liege. Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 1416
an immunogenic S. agalactiae protein in substantially pure form comprising a fragment of 100 or more consecutive amino acids from the amino acid sequence SEQ ID NO:3746, wherein the protein binds to specific antibodies raised against an S. agalactiae protein comprising the amino acid sequence SEQ ID NO:3746, wherein the specific antibodies do not bind to unrelated antigens; and\n
an adjuvant."],"number":4,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 4 which comprises a pharmaceutically acceptable carrier."],"number":5,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 4, wherein the immunogenic S. agalactiae protein is a recombinant protein."],"number":6,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 6, further comprising a pharmaceutically acceptable carrier."],"number":7,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 4, wherein the adjuvant comprises an aluminium salt."],"number":8,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 8 wherein the aluminium salt is alum."],"number":9,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 4, wherein the adjuvant comprises squalene, polyoxyethylene sorbitan monooleate, and sorbitan trioleate."],"number":10,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 5, wherein the adjuvant comprises an aluminium salt."],"number":11,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 11 wherein the aluminium salt is alum."],"number":12,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 5, wherein the adjuvant comprises squalene, polyoxyethylene sorbitan monooleate, and sorbitan trioleate."],"number":13,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 4, wherein the immunogenic S. agalactiae protein is an isolated protein."],"number":14,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 6, wherein the adjuvant comprises an aluminium salt."],"number":15,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 15, wherein the aluminium salt is alum."],"number":16,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 6, wherein the adjuvant comprises squalene, polyoxyethylene sorbitan monooleate, and sorbitan trioleate."],"number":17,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 14, wherein the adjuvant comprises an aluminium salt."],"number":18,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 18, wherein the aluminium salt is alum."],"number":19,"annotation":false,"title":false,"claim":true},{"lines":["The composition of claim 14, wherein the adjuvant comprises squalene, polyoxyethylene sorbitan monooleate, and sorbitan trioleate."],"number":20,"annotation":false,"title":false,"claim":true}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}